Breeze Study CA40934 LNK
Breeze Study CA40934 LNK
We are recruiting at our Lincoln, NE location for our 'Breeze' clinical study that pays up to $8,000 for time & commitment.
CA40934 Requirements Include:• Males & Females of Non-Childbearing Potential
• Ages: 19-55
• BMI: 18.00-32.00
About the Clinical Study
• Stipend: $8,000
• Length: Two- 6 Night Stays & 1 Phone Call
• This investigational medication is being developed to treat the most common type of dwarfism.
Study Schedule - Subject to Change
Group 1
• Study Start: 6/22/23
• Stipend: $8,000
• Length: Two- 6 Night Stays & 1 Phone Call
• This investigational medication is being developed to treat the most common type of dwarfism.
Study Schedule - Subject to Change
Group 1
• Study Start: 6/22/23
• Screening Dates through 6/7/23
Group 2
• Study Start: 7/6/23
Learn more
Fill out the form to receive a phone call within 24 hours from a Celerion Study Participant Representative.
Want to talk to a rep?
Want to learn more about Clinical Trials:
Group 2
• Study Start: 7/6/23
• Screening Dates through 6/21/23
Learn more
Fill out the form to receive a phone call within 24 hours from a Celerion Study Participant Representative.
Want to talk to a rep?
Study Participant Representatives at our Customer-Care-Center are available to answer questions.
1-866-445-7033
(United States Toll Free)
1-866-445-7033
(United States Toll Free)
Want to learn more about Clinical Trials:
From the Food and Drug Administration (FDA)
Why Healthy Subjects - Explainer Video
Celerion - Help Research - COVID Safety
Why Healthy Subjects - Explainer Video
Celerion - Help Research - COVID Safety
